Halozyme Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.1M | 53k | 40.68 |
| 2023-12-31 | $4.6M | 125k | 36.96 |
| 2023-09-30 | $2.7M | 71k | 38.20 |
| 2023-06-30 | $12M | 342k | 36.07 |
| 2023-03-31 | $17M | 453k | 38.19 |
| 2022-12-31 | $9.0M | 159k | 56.90 |
| 2022-09-30 | $551k | 14k | 39.54 |
| 2022-06-30 | $613k | 14k | 43.99 |
| 2022-03-31 | $989k | 25k | 39.89 |
| 2021-12-31 | $1.0M | 25k | 40.22 |
| 2021-09-30 | $927k | 23k | 40.68 |
| 2020-12-31 | $10M | 235k | 42.71 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management